Aigen Investment Management’s ResMed RMD Stock Holding History

Aigen Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,561	Closed	-$349K	–	1025
2025 Q1	$349K	Buy	+1,561	New	+$364K	0.06%	454
2023 Q3	–	Sell	-4,737	Closed	-$1.04M	–	1043
2023 Q2	$1.04M	Buy	4,737 +2,578	+119%	+$575K	0.15%	191
2023 Q1	$473K	Sell	2,159 -4,058	-65%	-$880K	0.07%	323
2022 Q4	$1.29M	Buy	+6,217	New	+$1.37M	0.18%	146
2021 Q4	–	Sell	-2,060	Closed	-$543K	–	1160
2021 Q3	$543K	Buy	+2,060	New	+$563K	0.1%	237
2020 Q4	–	Sell	-1,640	Closed	-$281K	–	1005
2020 Q3	$281K	Buy	+1,640	New	+$303K	0.04%	558

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Aigen Investment Management's RMD Position: Q2 2025 in Review

Aigen Investment Management sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,561 shares — an estimated $349K sold.

Aigen Investment Management first reported a position in RMD in Q3 2020 and held it in 6 quarters. The position peaked at $1.29M in Q4 2022. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Aigen Investment Management reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Aigen Investment Management sold 1,561 ResMed shares in Q2 2025, an estimated $349K.
Aigen Investment Management first reported a position in ResMed in Q3 2020 and held it in 6 quarters.
Aigen Investment Management's ResMed position peaked at $1.29M in Q4 2022.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Aigen Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.